Buscar
Mostrando ítems 51-60 de 103
Sex differences in heart failure with reduced ejection fraction in the GALACTIC-HF trial
(Elsevier on behalf of the American College of Cardiology Foundation, 2023-10-11)
[Abstract] Background: Women with heart failure with reduced ejection fraction (HFrEF) receive less guideline-recommended therapy and experience worse quality of life than men.
Objectives: The authors sought to assess ...
The consequences of the COVID‐19 pandemic for self‐care in patients supported with a left ventricular assist device
(European Society of Cardiology, 2020-06)
Spanish heart transplant registry. 33rd official report of the Heart failure Association of the Spanish Society of Cardiology
(Elsevier, 2022-07-16)
[Abstract] Introduction and objectives: This report updates the annual data of the Spanish Heart Transplant Registry with the procedures performed in 2021.
Methods: We describe the clinical profile, therapeutic ...
Indications, complications, and outcomes of cardiac surgery after heart transplantation: results from the cash study
(Frontiers, 2022-06-09)
[Abstract] Background: Allograft pathologies, such as valvular, coronary artery, or aortic disease, may occur early and late after cardiac transplantation. Cardiac surgery after heart transplantation (CASH) may be an option ...
Beneficial effects of essential oils from the mediterranean diet on gut microbiota and their metabolites in ischemic heart disease and type-2 diabetes mellitus
(MDPI, 2022-11-03)
[Abstract] Ischemic heart disease (IHD) and type-2 diabetes mellitus (T2DM) remain major health problems worldwide and commonly coexist in individuals. Gut microbial metabolites, such as trimethylamine N-oxide (TMAO) and ...
Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure
(Frontiers, 2022-04)
[Abstract] Introduction: Galectin-3 (Gal-3) is an inflammatory marker associated with the development and progression of heart failure (HF). A close relationship between Gal-3 levels and renal function has been observed, ...
HFA of the ESC Position Paper on the Management of LVAD-Supported Patients for the Non-LVAD Specialist Healthcare Provider Part 3: At the Hospital and Discharge
(Wiley, 2021-09-28)
[Abstract] The growing population of left ventricular assist device (LVAD)-supported patients increases the probability of an LVAD- supported patient hospitalized in the internal or surgical wards with certain expected ...
Specific Test Panels for Patients With Heart Failure: Implementation and Use in the Spanish National Health System
(De Gruyter, 2022-03-07)
[Abstract] Objectives. The use of specific test panels (STP) for heart failure (HF) could help improve the management of this condition. The purpose of this study is to gain an insight into the level of implementation of ...
Epidemiological study of tricuspid regurgitation after cardiac transplantation: does it influence survival?
(Frontiers, 2022-03-21)
[Abstract] Background: Tricuspid valve disease is the most frequent valvulopathy after heart transplantation (HTx). Evidence for the negative effect of post-transplant tricuspid regurgitation (TR) on survival is contradictory. ...
Specialized proresolving mediators protect against experimental autoimmune myocarditis by modulating Ca2+ handling and NRF2 activation
(Elsevier, 2022-05-18)
[Abstract] Specialized proresolving mediators and, in particular, 5(S), (6)R, 7-trihydroxyheptanoic acid methyl ester (BML-111) emerge as new therapeutic tools to prevent cardiac dysfunction and deleterious cardiac damage ...